Edition:
United Kingdom

argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

122.30EUR
1:45pm BST
Change (% chg)

€-0.90 (-0.73%)
Prev Close
€123.20
Open
€122.20
Day's High
€122.70
Day's Low
€120.50
Volume
30,273
Avg. Vol
121,529
52-wk High
€125.80
52-wk Low
€54.30

About

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)

Overall

Beta: --
Market Cap(Mil.): €583.54
Shares Outstanding(Mil.): 26.89
Dividend: --
Yield (%): --

Financials

  ARGX.BR Industry Sector
P/E (TTM): -- 69.29 32.55
EPS (TTM): -1.07 -- --
ROI: -19.69 8.90 13.82
ROE: -19.69 10.04 15.24

Earnings vs. Estimates